↓ Skip to main content

The polypill approach – An innovative strategy to improve cardiovascular health in Europe

Overview of attention for article published in BMC Pharmacology and Toxicology, February 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

8 tweeters


10 Dimensions

Readers on

59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
The polypill approach – An innovative strategy to improve cardiovascular health in Europe
Published in
BMC Pharmacology and Toxicology, February 2017
DOI 10.1186/s40360-016-0102-9
Pubmed ID

Valentín Fuster, Francesc Gambús, Aldo Patriciello, Margaretha Hamrin, Diederick E. Grobbee


Cardiovascular disease (CVD) is a major cause of disability and premature death. Despite European guidelines advocating the use of medical therapies in CVD, many patients still do not achieve the guideline-recommended treatment, which highlights the need for change and innovations in this field. This requirement has been widely recognised by the national ministries of health, several European cardiology societies, and the European Parliament, who support the initiation of strategies to improve and promote cardiovascular health. One of the key risk factors to recurrent cardiovascular events is the lack of adherence to medication and this has been added to the agenda of the European Commission. With the intention to improve treatment adherence in CVD, polypills have been investigated and numerous studies demonstrate that they significantly improve medication adherence, which contributes to the improvement of health outcomes. In Europe, the first cardiovascular polypill, developed by a public-private partnership (CNIC-Ferrer), recently became available for general prescription as a therapy for CVD prevention. This polypill significantly improves adherence, preventing fatal and non-fatal cardiovascular events, and appears to be a cost-effective strategy to improve sustainability of the health care systems in CVD. Given the importance of urgent and simple solutions to restraining the pandemic nature of CVD, the polypill approach should therefore be considered by physicians and public health systems as an available and innovative option to improve cardiovascular health.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Unknown 58 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 17%
Student > Master 9 15%
Student > Bachelor 9 15%
Student > Ph. D. Student 7 12%
Other 4 7%
Other 15 25%
Unknown 5 8%
Readers by discipline Count As %
Medicine and Dentistry 14 24%
Nursing and Health Professions 11 19%
Social Sciences 7 12%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 12 20%
Unknown 8 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2019.
All research outputs
of 15,703,546 outputs
Outputs from BMC Pharmacology and Toxicology
of 324 outputs
Outputs of similar age
of 357,716 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
of 2 outputs
Altmetric has tracked 15,703,546 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 324 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.